• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠通透性紊乱:病因、疾病与治疗。

Intestinal permeability disturbances: causes, diseases and therapy.

机构信息

Faculty of Health Sciences, Institute of Physiotherapy, Chair of Biomedical Sciences, Jagiellonian University Medical College, Kopernika 7a, 31-034, Kraków, Poland.

出版信息

Clin Exp Med. 2024 Sep 28;24(1):232. doi: 10.1007/s10238-024-01496-9.

DOI:10.1007/s10238-024-01496-9
PMID:39340718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11438725/
Abstract

Nowadays, a pathological increase in the permeability of the intestinal barrier (the so-called leaky gut) is increasingly being diagnosed. This condition can be caused by various factors, mainly from the external environment. Damage to the intestinal barrier entails a number of adverse phenomena: dysbiosis, translocation of microorganisms deep into the intestinal tissue, immune response, development of chronic inflammation. These phenomena can ultimately lead to a vicious cycle that promotes the development of inflammation and further damage to the barrier. Activated immune cells in mucosal tissues with broken barriers can migrate to other organs and negatively affect their functioning. Damaged intestinal barrier can facilitate the development of local diseases such as irritable bowel disease, inflammatory bowel disease or celiac disease, but also the development of systemic inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, hepatitis, and lupus erythematosus, neurodegenerative or psychiatric conditions, or metabolic diseases such as diabetes or obesity. However, it must be emphasized that the causal links between a leaky gut barrier and the onset of certain diseases often remain unclear and require in-depth research. In light of recent research, it becomes crucial to prevent damage to the intestinal barrier, as well as to develop therapies for the barrier when it is damaged. This paper presents the current state of knowledge on the causes, health consequences and attempts to treat excessive permeability of the intestinal barrier.

摘要

如今,越来越多的人被诊断出肠道屏障通透性病理性增加(即所谓的“肠漏”)。这种情况可能由多种因素引起,主要来自外部环境。肠道屏障受损会导致一系列不良现象:微生态失调、微生物向肠道组织深层移位、免疫反应、慢性炎症的发展。这些现象最终可能导致一个恶性循环,促进炎症的发展和进一步的屏障损伤。受损的黏膜组织中的免疫细胞可以迁移到其他器官,并对其功能产生负面影响。受损的肠道屏障会促进局部疾病的发展,如肠易激综合征、炎症性肠病或乳糜泻,但也会导致全身性炎症性疾病的发展,如类风湿关节炎、强直性脊柱炎、肝炎和狼疮,神经退行性或精神疾病,或代谢性疾病,如糖尿病或肥胖症。然而,必须强调的是,肠漏与某些疾病发作之间的因果关系往往仍不清楚,需要深入研究。鉴于最近的研究,预防肠道屏障损伤以及在其受损时开发针对该屏障的治疗方法变得至关重要。本文介绍了肠道屏障通透性过度的原因、对健康的影响以及治疗尝试的最新知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/11438725/52b20118a1a3/10238_2024_1496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/11438725/d39cd1224b3e/10238_2024_1496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/11438725/52b20118a1a3/10238_2024_1496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/11438725/d39cd1224b3e/10238_2024_1496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/11438725/52b20118a1a3/10238_2024_1496_Fig2_HTML.jpg

相似文献

1
Intestinal permeability disturbances: causes, diseases and therapy.肠通透性紊乱:病因、疾病与治疗。
Clin Exp Med. 2024 Sep 28;24(1):232. doi: 10.1007/s10238-024-01496-9.
2
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review.肠道微生物群、肠道通透性和全身炎症:叙述性综述。
Intern Emerg Med. 2024 Mar;19(2):275-293. doi: 10.1007/s11739-023-03374-w. Epub 2023 Jul 28.
3
Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity.肠道渗漏综合征的伙伴:肠道菌群失调与自身免疫。
Front Immunol. 2021 Apr 22;12:673708. doi: 10.3389/fimmu.2021.673708. eCollection 2021.
4
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis.针对 zonulin 和肠道上皮屏障功能以预防关节炎的发生。
Nat Commun. 2020 Apr 24;11(1):1995. doi: 10.1038/s41467-020-15831-7.
5
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis.肠道菌群失调和闭合蛋白上调改变强直性脊柱炎患者的肠道上皮和血管屏障。
Ann Rheum Dis. 2017 Jun;76(6):1123-1132. doi: 10.1136/annrheumdis-2016-210000. Epub 2017 Jan 9.
6
Aberrant Gut Microbiome Contributes to Intestinal Oxidative Stress, Barrier Dysfunction, Inflammation and Systemic Autoimmune Responses in MRL/lpr Mice.肠道微生物组的异常变化导致 MRL/lpr 小鼠肠道氧化应激、屏障功能障碍、炎症和全身自身免疫反应。
Front Immunol. 2021 Apr 12;12:651191. doi: 10.3389/fimmu.2021.651191. eCollection 2021.
7
Leaky Gut and the Ingredients That Help Treat It: A Review.肠漏症与有助于治疗它的成分:综述。
Molecules. 2023 Jan 7;28(2):619. doi: 10.3390/molecules28020619.
8
Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease.肠道屏障功能障碍在关节炎发病机制中起着重要作用,可以作为治疗靶点来改善疾病。
Med. 2021 Jul 9;2(7):864-883.e9. doi: 10.1016/j.medj.2021.04.013.
9
A Cascade of Microbiota-Leaky Gut-Inflammation- Is it a Key Player in Metabolic Disorders?微生物群-肠道渗漏-炎症的级联反应:它是代谢紊乱的关键因素吗?
Curr Obes Rep. 2025 Apr 10;14(1):32. doi: 10.1007/s13679-025-00624-0.
10
Targeting gut barrier dysfunction with phytotherapies: Effective strategy against chronic diseases.以植物疗法靶向肠道屏障功能障碍:防治慢性疾病的有效策略。
Pharmacol Res. 2020 Nov;161:105135. doi: 10.1016/j.phrs.2020.105135. Epub 2020 Aug 16.

引用本文的文献

1
Resistant Starch and Microbiota-Derived Secondary Metabolites: A Focus on Postbiotic Pathways in Gut Health and Irritable Bowel Syndrome.抗性淀粉与微生物群衍生的次级代谢产物:聚焦肠道健康和肠易激综合征中的后生元途径
Int J Mol Sci. 2025 Aug 11;26(16):7753. doi: 10.3390/ijms26167753.
2
The Effects of Prebiotic Dietary Fibers, Probiotics, and Synbiotics on Gut Permeability and Immunity: A Systematic Review.益生元膳食纤维、益生菌和合生元对肠道通透性及免疫的影响:一项系统综述
Iran J Med Sci. 2025 Aug 1;50(8):500-529. doi: 10.30476/ijms.2024.102363.3525. eCollection 2025 Aug.
3
subsp. dipro-O: a potential therapeutic agent for ameliorating metabolic disorders in high-fat diet-induced obesity mouse model.

本文引用的文献

1
Intestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise.肠道屏障通透性:肠道微生物群、营养和运动的影响
Front Physiol. 2024 Jul 8;15:1380713. doi: 10.3389/fphys.2024.1380713. eCollection 2024.
2
Combination treatment of inflammatory bowel disease: Present status and future perspectives.炎症性肠病的联合治疗:现状与未来展望。
World J Gastroenterol. 2024 Apr 21;30(15):2068-2080. doi: 10.3748/wjg.v30.i15.2068.
3
A Review of Available Medical Therapies to Treat Moderate-to-Severe Inflammatory Bowel Disease.
亚种双丙酮-O:一种用于改善高脂饮食诱导的肥胖小鼠模型中代谢紊乱的潜在治疗剂。
Front Endocrinol (Lausanne). 2025 Jun 6;16:1519058. doi: 10.3389/fendo.2025.1519058. eCollection 2025.
4
Intestinal Microbiota Dysbiosis Role and Bacterial Translocation as a Factor for Septic Risk.肠道微生物群失调的作用以及细菌易位作为脓毒症风险因素
Int J Mol Sci. 2025 Feb 26;26(5):2028. doi: 10.3390/ijms26052028.
5
Gut Microbiota and Liver Dysfunction in Sepsis: The Role of Inflammatory Mediators and Therapeutic Approaches.脓毒症中的肠道微生物群与肝功能障碍:炎症介质的作用及治疗方法
Int J Mol Sci. 2024 Dec 14;25(24):13415. doi: 10.3390/ijms252413415.
6
Biomarkers of Intestinal Permeability Are Influenced by Diet in Patients with Ulcerative Colitis-An Exploratory Study.溃疡性结肠炎患者肠道通透性生物标志物受饮食影响——一项探索性研究
Diagnostics (Basel). 2024 Nov 22;14(23):2629. doi: 10.3390/diagnostics14232629.
治疗中重度炎症性肠病的现有医学疗法综述。
Am J Gastroenterol. 2024 Jan 1;119(1):55-80. doi: 10.14309/ajg.0000000000002485. Epub 2023 Aug 24.
4
Fecal and Circulating Biomarkers for the Non-Invasive Assessment of Intestinal Permeability.用于肠道通透性无创评估的粪便和循环生物标志物
Diagnostics (Basel). 2023 Jun 5;13(11):1976. doi: 10.3390/diagnostics13111976.
5
Gut microbiota and hypertension: association, mechanisms and treatment.肠道微生物群与高血压:关联、机制与治疗。
Clin Exp Hypertens. 2023 Dec 31;45(1):2195135. doi: 10.1080/10641963.2023.2195135.
6
Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritis multiple pathways.肠道-关节轴:肠道菌群失调可通过多种途径导致类风湿关节炎的发病。
Front Cell Infect Microbiol. 2023 Jan 27;13:1092118. doi: 10.3389/fcimb.2023.1092118. eCollection 2023.
7
Leaky Gut and the Ingredients That Help Treat It: A Review.肠漏症与有助于治疗它的成分:综述。
Molecules. 2023 Jan 7;28(2):619. doi: 10.3390/molecules28020619.
8
The bridge of the gut-joint axis: Gut microbial metabolites in rheumatoid arthritis.肠道-关节轴桥:类风湿关节炎中的肠道微生物代谢产物。
Front Immunol. 2022 Oct 6;13:1007610. doi: 10.3389/fimmu.2022.1007610. eCollection 2022.
9
Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control.类风湿性关节炎与肠道通透性增加和细菌易位有关,而炎症控制可使其逆转。
Rheumatology (Oxford). 2022 Aug 10. doi: 10.1093/rheumatology/keac454.
10
Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.薬用人形草(さいにんにんぎょうそう)は、日本のハーブ薬であり、抗生物質誘導性ディシビオシスに伴う腸漏れを緩和する。
PLoS One. 2022 Jun 15;17(6):e0269698. doi: 10.1371/journal.pone.0269698. eCollection 2022.